港股異動丨美國“對等關稅”遠超預期,出口型企業大跌,申洲國際跌超17%
特朗普“對等關稅”落地,全面徵收,遠超預期!港股市場出口型企業股價走低。其中,申洲國際(2313.HK)跌超17%,創科實業(0669.HK)跌近9%,敏華控股跌超8%,海爾智家跌近7%。消息面上,特朗普“對等關稅”落地,遠超預期!全面徵收,設10%“最低基準關稅”,對其他被認爲在貿易活動中表現不佳的國家,則徵收更高的稅率。其中,中國被開徵34%關稅,對歐盟徵收20%,向柬埔寨開徵49%關稅,越南被徵46%,泰國徵收36%,向印尼徵收32%,向韓國開徵25%,馬來西亞加徵24%,日本被徵24%,英國徵收10%。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.